Sign Out
Warnings: It is recommended to use a suitable analgesic oral treatment as soon as this administration route is possible. In order to avoid the risk of overdose, check that other medicines administered do not contain either paracetamol or propacetamol. Doses higher than the recommended entails risk for very serious liver damage. Clinical symptoms and signs of liver damage (including fulminant hepatitis, hepatic failure, cholestatic hepatitis, cytolytic hepatitis) are usually first seen after two days of drug administration with a peak seen usually after 4-6 days. Treatment with antidote should be given as soon as possible.
Allergy Alert: Paracetamol may cause severe skin reactions. Symptoms may include skin reddening, blisters or rash. These could be signs of serious condition. If these reactions occur, stop use and seek medical assistance right away.
This product contains sodium sulfite anhydrous (E221), a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible persons.
This medicinal product contains less than 1 mmol sodium (23 mg) per 100 ml of INFULGAN, i.e. essentially "sodium free".
Text for the 20 ml and 100 ml bottles: As for all solutions for infusion in glass bottles, a close monitoring is needed notably at the end of infusion.
